Showing results (91-100 of 118) with videos related to
Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2020
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practiceVikas Prasad, Raj Srirajaskanthan, Christos Toumpanakis, et al.Journal of the American College of Cardiology|March 11, 2017
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert StatementJoseph Davar, Heidi M Connolly, Martyn E Caplin, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2025
The indolent nature of type 1 gastric neuroendocrine tumors under 1 cmElisabetta Dell'Unto, Dalvinder Mandair, George Riding, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
[18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter StudyDavid L Chan, Aimee Hayes, Ioannis Karfis, et al.Frontiers in Oncology|March 15, 2021
Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine NeoplasmsFaidon-Marios Laskaratos, Ana Levi, Gert Schwach, et al.Neuroendocrinology|September 20, 2020
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 PatientsAimee R Hayes, Ingrid Y F Mak, Nicholas Evans, et al.Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
[18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter StudyDavid L Chan, Aimee R Hayes, Ioannis Karfis, et al.Neuroendocrinology|September 21, 2018
Unmet Needs in Appendiceal Neuroendocrine NeoplasmsChristos Toumpanakis, Nicola Fazio, Eva Tiensuu Janson, et al.British Journal of Cancer|January 15, 2019
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumoursFrancesca M Rizzo, Clare Vesely, Alexa Childs, et al.Pageof 12